DENTSPLY SIRONA Inc. (XRAY) — financial distillation

S&P 400 · United States · Nasdaq

XRAYCIK 0000818479Period ends 2026-06-30Distilled SEC EDGAR XBRL company facts

Annual history (10-K)

Quarterly history (10-Q)

Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.

In brief, from the full filed history

  • Revenue grew from $2.01B (period ending 2007-12-31) to $3.68B (period ending 2025-12-31) — a 3.4% annual pace across 18 year(s) of filed history.
  • Net margin turned from a 12.9% margin to a loss (-16.3%) over that same span.
  • Across 54 tracked quarters, the strongest was $1.07B (quarter ending 2021-09-30) and the weakest was $0 (quarter ending 2015-03-31).

Annual — most recent 10-K

Line Value Period ends Form Filing
Revenue $3.68B 2025-12-31 10-K 0000818479-26-000075
Gross profit $1.84B 2025-12-31 10-K 0000818479-26-000075
Operating income $-422.0M 2025-12-31 10-K 0000818479-26-000075
Net income $-598.0M 2025-12-31 10-K 0000818479-26-000075
Diluted EPS $-3.00 2025-12-31 10-K 0000818479-26-000075
Total assets $5.43B 2025-12-31 10-K 0000818479-26-000075
Total liabilities $4.09B 2025-12-31 10-K 0000818479-26-000075
Cash & equivalents $326.0M 2025-12-31 10-K 0000818479-26-000075
Operating cash flow $235.0M 2025-12-31 10-K 0000818479-26-000075

Quarterly — most recent 10-Q

Line Value Period ends Form Filing
Revenue $898.0M 2026-06-30 10-Q 0000818479-26-000255
Gross profit $493.0M 2026-06-30 10-Q 0000818479-26-000255
Operating income $82.0M 2026-06-30 10-Q 0000818479-26-000255
Net income $37.0M 2026-06-30 10-Q 0000818479-26-000255
Diluted EPS $0.18 2026-06-30 10-Q 0000818479-26-000255
Total assets $5.20B 2026-06-30 10-Q 0000818479-26-000255
Total liabilities $3.85B 2026-06-30 10-Q 0000818479-26-000255
Cash & equivalents $239.0M 2026-06-30 10-Q 0000818479-26-000255
Operating cash flow $40.0M 2026-03-31 10-Q 0000818479-26-000149

Reading

The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.

DENTSPLY SIRONA Inc. (XRAY) operates in the dental industry, as evidenced by its annual revenue of $3.68 billion for the period ending December 31, 2025. Over an 18-year span, from 2007 to 2025, the company’s revenue grew at a modest 3.4% annual pace, as per pre-computed trend facts. However, net income has experienced significant volatility, transitioning from a profit margin of 12.9% in 2007 to a loss of -16.3% by 2025.

The company’s operating cash flow, at $235 million for the year ending December 31, 2025, and $40 million for the quarter ending June 30, 2026, indicates a capacity to generate cash from operations. Nevertheless, the most recent net income stands at -$598 million for the year ending December 31, 2025, and -$598.0 million for the preceding year, reflecting substantial losses.

In monitoring future filings, investors should pay close attention to DENTSPLY SIRONA’s ability to stabilize its net income and improve profitability, given the historical trend of declining margins and periodic losses. Additionally, the company’s management strategies to enhance revenue growth while controlling costs will be crucial factors in determining future financial health.


Source: SEC EDGAR company facts for CIK 0000818479 · filings index